PODCAST: Auditory brain stem implants in young children.

Podcast

Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.

Jamie Glater, MD, assistant professor of clinical otolaryngology at the University of Southern California (USC) and faculty member at the USC Caruso Family Center for Childhood Communication, speaks with Contemporary Pediatrics about a National Institutes of Health-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis. 

Recent Videos
H. Westley Phillips, MD
H. Westley Phillips, MD
Alan Percy, MD
Alan Percy, MD
DB-OTO improved hearing to normal in child with profound genetic deafness | Image Credit: © Marija - © Marija - stock.adobe.com.
William Gallentine, DO
Rob Knight, PhD | Image Credit: Contemporary Pediatrics®
Image credit: Kyle Dykes
Related Content
Using a smartphone application to screen for neonatal jaundice | Image Credit: © zilvergolf - © zilvergolf - stock.adobe.com.

Using a smartphone application to screen for neonatal jaundice

Joshua Fitch, Senior Editor
December 11th 2024
Article

A good correlation and statistical agreement with total serum bilirubin was observed in a study of a new smartphone-based machine learning app, leaving it a potential neonatal jaundice screening tool.

Survey: trofinetide improves tolerability among Rett syndrome patients | Image Credit: © ARBA - © ARBA - stock.adobe.com.

Survey: titrating trofinetide improves tolerability among Rett syndrome patients

Joshua Fitch, Senior Editor
December 9th 2024
Article

Respondents reported decreased diarrhea severity, improved patient quality of life, and decreased treatment discontinuation among patients with Rett syndrome treated with trofinetide.

Fremanezumab for episodic migraine prevention demonstrates positive phase 3 dataLatest revision | Image Credit: © Jan H. Andersen - © Jan H. Andersen - stock.adobe.com.

Fremanezumab for episodic migraine prevention demonstrates positive phase 3 data

Joshua Fitch, Senior Editor
December 4th 2024
Article

Both monthly migraine days and headache days were reduced vs placebo in patients aged 6 to 17 years.

Saol Therapeutics submits NDA for SL1009 to treat Pyruvate Dehydrogenase Complex Deficiency | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

Saol Therapeutics submits NDA for SL1009 to treat Pyruvate Dehydrogenase Complex Deficiency

Joshua Fitch, Senior Editor
December 3rd 2024
Article

If approved, SL1009 has the potential to be the first approved medication for PDCD, and would be available as an oral solution.

Study: Concussions slow aperiodic activity among high school football players | Image Credit: © Skip Monday - © Skip Monday - stock.adobe.com.

Study: Concussions slow aperiodic activity among high school football players

Joshua Fitch, Senior Editor
November 27th 2024
Article

Results demonstrated that slowed aperiodic activity was present in brain areas linked to concussion symptoms such as impaired concentration and memory.

Weekly report: Phase 3 data for JNJ2113, expert discussions, and more

Joshua Fitch, Senior Editor
November 25th 2024
Article

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from last week, all in one place.

© 2024 MJH Life Sciences

All rights reserved.